Literature DB >> 1964829

Distribution of mu, delta, and kappa opioid receptors in the hypothalamus of the rat.

G C Desjardins1, J R Brawer, A Beaudet.   

Abstract

The radioautographic distribution of mu, delta and kappa opioid binding sites was examined by in vitro radioautography in the rat hypothalamus using the highly selective ligands [125I]-FK 33-824, [125I]azidoDTLET and [125I]DPDYN, respectively. Levels of mu opioid binding sites varied considerably amongst hypothalamic nuclei. mu Opioid labeling was dense in the medial preoptic area, medial preoptic nucleus, suprachiasmatic nucleus and ventromedial nucleus, whilst the supraoptic nucleus, paraventricular nucleus, arcuate nucleus and dorsomedial nucleus were devoid of labeling. Delta opioid labeling was sparse throughout most of the hypothalamus; however, moderate binding densities were detected in the suprachiasmatic and ventromedial nucleus. kappa Opioid labeling was also scant throughout the hypothalamus with the exception of the suprachiasmatic nucleus which was very densely labeled. Our results indicate that the 3 opioid receptors types are differentially distributed within the hypothalamus, although a significant overlap exists. In general, the distribution of hypothalamic opioid receptors correlates well with that of opioid-containing terminal fibers and may represent the anatomical substrate for opioid involvement in the hypothalamic regulation of autonomic, behavioral and neuroendocrine functions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964829     DOI: 10.1016/0006-8993(90)90015-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  Tonic inhibitory control exerted by opioid peptides in the paraventricular nuclei of the hypothalamus on regional hemodynamic activity in rats.

Authors:  Andrée Lessard; Hélène Bachelard
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

2.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

3.  The contribution of serotonin 1A receptors to kappa opioid immunosuppression.

Authors:  M A Cheido; G V Idova
Journal:  Neurosci Behav Physiol       Date:  2009-06-11

4.  Influence of endomorphins along the pituitary-ovary axis in the Mozambique Tilapia Oreochromis mossambicus.

Authors:  C B Ganesh
Journal:  Fish Physiol Biochem       Date:  2019-11-27       Impact factor: 2.794

5.  Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1/2 and GSK3β kinases and Per1 expression in the rat suprachiasmatic nucleus.

Authors:  Dominika Pačesová; Barbora Volfová; Kateřina Červená; Lucie Hejnová; Jiří Novotný; Zdeňka Bendová
Journal:  Br J Pharmacol       Date:  2015-05-11       Impact factor: 8.739

6.  Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone.

Authors:  Sarita Naik; Renata Belfort-DeAguiar; Anne-Sophie Sejling; Barbara Szepietowska; Robert S Sherwin
Journal:  Diabetes Obes Metab       Date:  2017-02-17       Impact factor: 6.577

7.  Effect of prodynorphin-derived opioid peptides on the ovulatory luteinizing hormone surge in the proestrous rat.

Authors:  Qiang Zhang; Robert V Gallo
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

8.  Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake.

Authors:  Jessica R Barson; Ambrose J Carr; Jennifer E Soun; Nasim C Sobhani; Pedro Rada; Sarah F Leibowitz; Bartley G Hoebel
Journal:  Alcohol Clin Exp Res       Date:  2009-11-24       Impact factor: 3.455

Review 9.  The association of sleep and pain: an update and a path forward.

Authors:  Patrick H Finan; Burel R Goodin; Michael T Smith
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

10.  κ-Opioid Receptor Is Colocalized in GnRH and KNDy Cells in the Female Ovine and Rat Brain.

Authors:  Peyton W Weems; Christine F Witty; Marcel Amstalden; Lique M Coolen; Robert L Goodman; Michael N Lehman
Journal:  Endocrinology       Date:  2016-04-11       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.